What the FDA labels say about taking them together
Oteseconazole and rosuvastatin
Oteseconazole's FDA label of January 8, 2026 names rosuvastatin in its drug interactions section; the rosuvastatin labels PlainMeds reads (2) do not name oteseconazole. The oteseconazole label: “Concomitant use of VIVJOA with BCRP substrates (e.g., rosuvastatin) may increase the exposure of BCRP substrates (e.g., rosuvastatin), which may increase the risk of adverse reactions associated with these drugs.”
Check it at the source: the oteseconazole FDA label on DailyMed (effective January 8, 2026, Mycovia Pharmaceuticals, Inc.); the rosuvastatin FDA label on DailyMed (effective September 4, 2026, ScieGen Pharmaceuticals, Inc.).
What does the oteseconazole label say about rosuvastatin?
Oteseconazole label, drug interactionsConcomitant use of VIVJOA with BCRP substrates (e.g., rosuvastatin) may increase the exposure of BCRP substrates (e.g., rosuvastatin), which may increase the risk of adverse reactions associated with these drugs.
Source: FDA drug label (VIVJOA), Mycovia Pharmaceuticals, Inc., effective January 8, 2026 (SPL set e21d5008-800e-4417-927f-14340341865f), via openFDA; the full label on DailyMed
What does the rosuvastatin label say about oteseconazole?
Rosuvastatin's label (effective September 4, 2026) and its 1 other brand-application label do not name oteseconazole in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Rosuvastatin), ScieGen Pharmaceuticals, Inc., effective September 4, 2026 (SPL set ee4933c5-0d97-494d-ac0f-2083e0100836), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Oteseconazole | Rosuvastatin | |
|---|---|---|
| Labeled for | n/a | Heart attack and coronary artery disease, High cholesterol, High triglycerides, Stroke prevention |
| Boxed warning | No | No |
| Pharmacy cost (NADAC) | n/a | $0.0692 per tablet 40 mg tablet |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once